DE60116758D1 - Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform - Google Patents
Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsformInfo
- Publication number
- DE60116758D1 DE60116758D1 DE60116758T DE60116758T DE60116758D1 DE 60116758 D1 DE60116758 D1 DE 60116758D1 DE 60116758 T DE60116758 T DE 60116758T DE 60116758 T DE60116758 T DE 60116758T DE 60116758 D1 DE60116758 D1 DE 60116758D1
- Authority
- DE
- Germany
- Prior art keywords
- toxic
- drug
- region
- potent
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20589600P | 2000-05-18 | 2000-05-18 | |
US205896P | 2000-05-18 | ||
PCT/US2001/040763 WO2001087272A2 (en) | 2000-05-18 | 2001-05-18 | Encapsulating a toxic core within a non-toxic region in an oral dosage form |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60116758D1 true DE60116758D1 (de) | 2006-04-06 |
DE60116758T2 DE60116758T2 (de) | 2006-11-02 |
Family
ID=22764098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60116758T Expired - Lifetime DE60116758T2 (de) | 2000-05-18 | 2001-05-18 | Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform |
Country Status (9)
Country | Link |
---|---|
US (2) | US7276252B2 (de) |
EP (1) | EP1286663B1 (de) |
JP (2) | JP5178982B2 (de) |
AT (1) | ATE315930T1 (de) |
AU (1) | AU2001263506A1 (de) |
CA (1) | CA2408956C (de) |
DE (1) | DE60116758T2 (de) |
ES (1) | ES2257412T3 (de) |
WO (1) | WO2001087272A2 (de) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US6518330B2 (en) * | 2001-02-13 | 2003-02-11 | Board Of Trustees Of University Of Illinois | Multifunctional autonomically healing composite material |
JP2005509001A (ja) * | 2001-10-29 | 2005-04-07 | セリクス, インコーポレイテッド | 投薬形態の三次元懸濁液プリンティング |
EP1441703B1 (de) | 2001-10-29 | 2018-01-03 | Massachusetts Institute of Technology | Dosierungsformen mit zero-order freigabe hergestellt durch dreidimensionales drucken |
US7931914B2 (en) * | 2001-10-29 | 2011-04-26 | Massachusetts Institute Of Technology | System and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form |
AU2003232078A1 (en) | 2002-05-06 | 2003-11-17 | Massachusetts Institute Of Technology | Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
JP2006528189A (ja) * | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質産物、その使用法および製剤 |
WO2005009364A2 (en) * | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005009368A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
EP1653925A1 (de) * | 2003-08-11 | 2006-05-10 | Advancis Pharmaceutical Corporation | Robustes pellet |
CA2535398C (en) | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
US8246996B2 (en) * | 2003-08-29 | 2012-08-21 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
CA2538064C (en) * | 2003-09-15 | 2013-12-17 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
US20050087902A1 (en) * | 2003-10-28 | 2005-04-28 | Isaac Farr | Alginate-based materials, methods of application thereof, and systems for using the alginate-based materials |
AU2004308419B2 (en) * | 2003-12-24 | 2011-06-02 | Victory Pharma, Inc. | Enhanced absorption of modified release dosage forms |
US7566747B2 (en) * | 2004-05-07 | 2009-07-28 | The Board Of Trustees Of The University Of Illinois | Wax particles for protection of activators, and multifunctional autonomically healing composite materials |
TWI356036B (en) * | 2004-06-09 | 2012-01-11 | Smithkline Beecham Corp | Apparatus and method for pharmaceutical production |
US20060002594A1 (en) * | 2004-06-09 | 2006-01-05 | Clarke Allan J | Method for producing a pharmaceutical product |
JPWO2006004069A1 (ja) * | 2004-07-01 | 2008-04-24 | 日本碍子株式会社 | 微小カプセルおよびその製造方法 |
WO2006014427A1 (en) * | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
WO2006058247A2 (en) * | 2004-11-26 | 2006-06-01 | Aprecia Pharmaceuticals Co. | Dosage forms and methods of use thereof |
US7829000B2 (en) * | 2005-02-25 | 2010-11-09 | Hewlett-Packard Development Company, L.P. | Core-shell solid freeform fabrication |
US7612152B2 (en) * | 2005-05-06 | 2009-11-03 | The Board Of Trustees Of The University Of Illinois | Self-healing polymers |
US7914776B2 (en) * | 2005-10-07 | 2011-03-29 | Adolor Corporation | Solid dispersions of opioid antagonists |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) * | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US7723405B2 (en) * | 2006-01-05 | 2010-05-25 | The Board Of Trustees Of The University Of Illinois | Self-healing coating system |
GB0608402D0 (en) * | 2006-04-28 | 2006-06-07 | Diurnal Ltd | Thyroid treatment |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
US7569625B2 (en) * | 2006-06-02 | 2009-08-04 | The Board Of Trustees Of The University Of Illinois | Self-healing elastomer system |
DE602007006492D1 (de) | 2006-07-25 | 2010-06-24 | Lipoxen Technologies Ltd | Derivatisierung des granulozytenkoloniestimulierenden faktors |
US20080107725A1 (en) * | 2006-10-13 | 2008-05-08 | Albano Antonio A | Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers |
US20080299391A1 (en) * | 2007-05-31 | 2008-12-04 | White Scott R | Capsules, methods for making capsules, and self-healing composites including the same |
WO2009007969A2 (en) * | 2007-07-09 | 2009-01-15 | Colint Ltd. | Portable hydration apparatus |
US20090181254A1 (en) * | 2008-01-15 | 2009-07-16 | The Board Of Trustees Of The University Of Illinois | Multi-capsule system and its use for encapsulating active agents |
JP2011074015A (ja) * | 2009-09-30 | 2011-04-14 | Tomita Pharmaceutical Co Ltd | 固形製剤及びその製造方法 |
DE102010051743B4 (de) | 2010-11-19 | 2022-09-01 | C. Miethke Gmbh & Co. Kg | Programmierbares Hydrocephalusventil |
KR101869127B1 (ko) * | 2011-05-25 | 2018-06-19 | 다이호야쿠힌고교 가부시키가이샤 | 테가푸르, 기메라실 및 오테라실칼륨 함유 구강내 붕괴정 |
US9381154B2 (en) * | 2011-06-09 | 2016-07-05 | Xerox Corporation | Direct inkjet fabrication of drug delivery devices |
US8414654B1 (en) * | 2011-11-23 | 2013-04-09 | Amendia, Inc. | Bone implants and method of manufacture |
CN102551927A (zh) * | 2011-11-29 | 2012-07-11 | 上海大学 | 嵌入式分级释药三维支架及其制备方法 |
US8888480B2 (en) | 2012-09-05 | 2014-11-18 | Aprecia Pharmaceuticals Company | Three-dimensional printing system and equipment assembly |
IN2015DN01776A (de) | 2012-09-05 | 2015-05-29 | Aprecia Pharmaceuticals Co | |
US20140099351A1 (en) * | 2012-10-04 | 2014-04-10 | Axxia Pharmaceuticals, Llc | Process for making controlled release medical implant products |
US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
CA2906172C (en) | 2013-03-15 | 2021-12-21 | Aprecia Pharmaceuticals Company | Rapidly dispersible dosage form of topiramate |
CN109908355B (zh) | 2013-03-15 | 2022-11-15 | 阿普雷奇亚制药有限责任公司 | 包含左乙拉西坦的快速分散剂型 |
ES2761265T3 (es) * | 2013-03-15 | 2020-05-19 | Aprecia Pharmaceuticals LLC | Forma de dosificación de oxcarbazepina rápidamente dispersable |
US10471497B2 (en) | 2013-08-16 | 2019-11-12 | The Exone Company | Three-dimensional printed metal-casting molds and methods for making the same |
EP3057729A4 (de) | 2013-10-17 | 2017-10-18 | The Exone Company | Isostatische heisspressbehälter mit 3d-druck und verfahren zur herstellung davon |
WO2015100084A1 (en) | 2013-12-23 | 2015-07-02 | The Exone Company | Method of three-dimensional printing using a multi-component build powder |
ES2745763T3 (es) | 2013-12-23 | 2020-03-03 | The Exone Co | Métodos y sistemas para la impresión en tres dimensiones utilizando múltiples fluidos aglutinantes |
WO2015130963A2 (en) | 2014-02-27 | 2015-09-03 | Xenetic Biosciences, Inc. | Compositions and methods for administering insulin or insulin-like protein to the brain |
EP3148730A1 (de) | 2014-05-29 | 2017-04-05 | The Exone Company | Verfahren zur herstellung von superlegierungsartikeln auf nickelbasis durch dreidimensionales drucken |
US20170203514A1 (en) | 2014-07-17 | 2017-07-20 | The Exone Company | Methods and Apparatuses for Curing Three-Dimensional Printed Articles |
US9854828B2 (en) | 2014-09-29 | 2018-01-02 | William Langeland | Method, system and apparatus for creating 3D-printed edible objects |
ES2832588T3 (es) | 2014-12-03 | 2021-06-10 | The Exone Co | Proceso para fabricar artículos de carbono densificados mediante impresión tridimensional |
WO2016192680A1 (en) | 2015-06-03 | 2016-12-08 | Triastek, Inc. | Dosage forms and use thereof |
RU2018109736A (ru) | 2015-08-21 | 2019-09-23 | АПРЕЦИЯ ФАРМАСЬЮТИКАЛЗ ЭлЭлСи | Система и аппаратный агрегат трехмерной печати |
EP3364946A4 (de) | 2015-10-23 | 2019-06-26 | Lyndra, Inc. | Magenverweilsysteme zur verzögerten freisetzung von therapeutischen wirkstoffen und verfahren zu deren verwendung |
JP6878417B2 (ja) * | 2016-02-17 | 2021-05-26 | トリアステック インコーポレイテッド | 剤形およびそれらの使用 |
KR101965283B1 (ko) | 2016-05-05 | 2019-04-03 | 트리아스텍 인코포레이티드 | 제어 방출 제형 |
US10765658B2 (en) | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
GB201612853D0 (en) | 2016-07-25 | 2016-09-07 | Univ Central Lancashire | Solid dosage form production |
JP2019532947A (ja) | 2016-09-30 | 2019-11-14 | リンドラ,インコーポレイティド | アダマンタン系薬物の持続的送達のための胃内滞留システム |
GB201620066D0 (en) | 2016-11-28 | 2017-01-11 | Ucl Business Plc | Solid Pharmaceutical dosage formulations and processes |
WO2018156141A1 (en) | 2017-02-24 | 2018-08-30 | Hewlett-Packard Development Company, L.P. | Three-dimensional (3d) printing a pharmaceutical tablet |
GR1009361B (el) | 2017-05-11 | 2018-09-17 | Κωνσταντινος Ηλια Θεοδοσοπουλος | Συστημα παραγωγης μεσω τρισδιαστατης εκτυπωσης, δισκιων, κοκκιων και καψουλων |
KR102626745B1 (ko) | 2017-05-26 | 2024-01-17 | 인피니트 머티리얼 솔루션즈, 엘엘씨 | 수용성 중합체 조성물 |
US10350822B1 (en) | 2018-01-09 | 2019-07-16 | Triastek Inc. | Dosage forms with desired release profiles and methods of designing and making thereof |
CN116270513A (zh) | 2018-01-09 | 2023-06-23 | 南京三迭纪医药科技有限公司 | 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型 |
DE102018107585B3 (de) * | 2018-03-29 | 2019-03-28 | Universität Rostock | Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen |
IT201800004265A1 (it) | 2018-04-06 | 2019-10-06 | Apparato e metodo per la produzione automatizzata di forme di dosaggio personalizzabili. | |
WO2020081561A1 (en) | 2018-10-15 | 2020-04-23 | Aprecia Pharmaceuticals LLC | Method and system for forming a dosage form within a packaging |
CN113557001B (zh) * | 2019-01-07 | 2023-10-20 | 卢克斯坎创新私人有限责任公司 | 用于将粉末状、液体状、糊状、包封的或颗粒状活性成分组合物压片的装置 |
US11724486B2 (en) | 2019-07-09 | 2023-08-15 | Kyndryl, Inc. | Printing customized medication based on current user data and medical records of the user |
GB201913972D0 (en) | 2019-09-27 | 2019-11-13 | Univ Ulster | Pharmaceutical Delivery Device and method of manufacture |
EP4171518A1 (de) | 2020-06-26 | 2023-05-03 | Aprecia Pharmaceuticals LLC | Schnell im mund dispergierbare tabletten mit einem inneren hohlraum |
EP4238556A1 (de) | 2020-10-30 | 2023-09-06 | Triastek, Inc. | Gastroretentive pharmazeutische darreichungsform |
GB2608846A (en) * | 2021-07-14 | 2023-01-18 | Quay Pharmaceuticals Ltd | Method and apparatus for additive manufacturing |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2801203A (en) * | 1951-03-22 | 1957-07-30 | Byk Gulden Lomberg Chem Fab | X-ray method of digestive enzyme diagnosis using protected core of contrast agent |
US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
US5082669A (en) | 1989-07-20 | 1992-01-21 | Dainippon Pharmaceutical Co., Ltd. | Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked |
US5215989A (en) | 1989-12-08 | 1993-06-01 | Merck & Co., Inc. | Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents |
US5314696A (en) * | 1991-06-27 | 1994-05-24 | Paulos Manley A | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
WO1994009762A1 (en) | 1992-11-05 | 1994-05-11 | Merck & Co., Inc. | Drug delivery device |
US6280771B1 (en) * | 1997-02-20 | 2001-08-28 | Therics, Inc. | Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof |
ZA949929B (en) * | 1993-12-23 | 1995-08-23 | Akzo Nobel Nv | Sugar-coated pharmaceutical dosage unit. |
JPH07223970A (ja) | 1994-02-10 | 1995-08-22 | Tanabe Seiyaku Co Ltd | 消化管内適所放出製剤 |
ES2188657T3 (es) * | 1994-04-22 | 2003-07-01 | Yamanouchi Pharma Co Ltd | Sistema para la liberacion especifica en el colon de un farmaco. |
US5597829A (en) * | 1994-05-09 | 1997-01-28 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of camptothecin and methods for uses thereof |
US5783212A (en) * | 1996-02-02 | 1998-07-21 | Temple University--of the Commonwealth System of Higher Education | Controlled release drug delivery system |
WO1998036739A1 (en) * | 1997-02-20 | 1998-08-27 | Therics, Inc. | Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof |
US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
US6294199B1 (en) * | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
-
2001
- 2001-05-18 DE DE60116758T patent/DE60116758T2/de not_active Expired - Lifetime
- 2001-05-18 AU AU2001263506A patent/AU2001263506A1/en not_active Abandoned
- 2001-05-18 ES ES01937808T patent/ES2257412T3/es not_active Expired - Lifetime
- 2001-05-18 WO PCT/US2001/040763 patent/WO2001087272A2/en active IP Right Grant
- 2001-05-18 CA CA2408956A patent/CA2408956C/en not_active Expired - Fee Related
- 2001-05-18 US US09/861,480 patent/US7276252B2/en not_active Expired - Lifetime
- 2001-05-18 AT AT01937808T patent/ATE315930T1/de not_active IP Right Cessation
- 2001-05-18 JP JP2001583741A patent/JP5178982B2/ja not_active Expired - Fee Related
- 2001-05-18 EP EP01937808A patent/EP1286663B1/de not_active Expired - Lifetime
-
2005
- 2005-10-07 US US11/246,910 patent/US7875290B2/en not_active Expired - Fee Related
-
2012
- 2012-01-25 JP JP2012012834A patent/JP2012082224A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1286663B1 (de) | 2006-01-18 |
US7276252B2 (en) | 2007-10-02 |
WO2001087272A3 (en) | 2002-04-18 |
DE60116758T2 (de) | 2006-11-02 |
WO2001087272A2 (en) | 2001-11-22 |
ES2257412T3 (es) | 2006-08-01 |
JP2012082224A (ja) | 2012-04-26 |
US20060110443A1 (en) | 2006-05-25 |
US7875290B2 (en) | 2011-01-25 |
EP1286663A2 (de) | 2003-03-05 |
JP2003533470A (ja) | 2003-11-11 |
JP5178982B2 (ja) | 2013-04-10 |
CA2408956A1 (en) | 2001-11-22 |
ATE315930T1 (de) | 2006-02-15 |
US20020015728A1 (en) | 2002-02-07 |
CA2408956C (en) | 2011-07-12 |
AU2001263506A1 (en) | 2001-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60116758D1 (de) | Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform | |
KR870000068A (ko) | 경구용 약제 조성물 | |
TR200100144T2 (tr) | Farmasötik aerosol formülasyonu | |
NO332857B1 (no) | Inhalasjonskapsel samt anvendelse av slike | |
DE69936730D1 (de) | Pharmazeutische aerosolzubereitung, die hfa227 und hfa 134a enthält | |
JP2007513152A (ja) | 耐湿性容器内のチオトロピウムから構成される医薬製品 | |
TNSN06277A1 (en) | Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient | |
ES2195342T3 (es) | Formulacion farmaceutica de omeprazol. | |
AR018891A1 (es) | Inhaladores presurizados de dosificacion medida y formulaciones farmaceuticas en aerosol | |
UY26232A1 (es) | Sistemas y métodos para aerosolizar formulaciones farmaceuticas bajo ley 17.164 | |
GB9410222D0 (en) | Medicaments | |
ES2196382T3 (es) | Administracion y envase de medicamentos. | |
MA26892A1 (fr) | Formulations pharmaceutiques sous forme de comprimes pour inhalateurs a parer | |
ATE271383T1 (de) | Pulverformulierung zur inhalation | |
TR200502522T2 (tr) | Çözünmez bir aktif madde içeren farmasötik formülasyon | |
JP2014509313A5 (de) | ||
WO2006008517A3 (en) | Use of dry powder compositions for pulmonary delivery | |
DK1207756T3 (da) | Anvendelse af spinosad eller en formulering, der omfatter spinosad | |
RU2006146870A (ru) | Минимизация удержания порошка на поверхностях | |
DE60313296D1 (de) | Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten | |
GR900100280A (el) | Αντιμυκητικα μεσα αζωλης υπο μορφην αεροζολ. | |
MX2009000849A (es) | Formas de dosificacion liofilizadasdisolvibles oralmente/desintegrables que contienen particulas protegidas. | |
ES2185452A1 (es) | Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion. | |
HUT57203A (en) | Process for substituted benzimidazol and paharmaceutical composition containing them | |
BRPI0607990A2 (pt) | formulação de um aerossol farmacêutico para inaladores dosimetrados pressurizados contendo um agente seqüestrante, uso do agente sequestrante, inalador de dosimetrado pressurizado e método de preenchimento do inalador de aerossol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: MASSACHUSETTS INSTITUTE OF TECHNOLOGY, CAMBRID, US |